Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiko Shimura

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Scientific Reports|May 10, 2020
Functional and anatomical changes in diabetic macular edema after hemodialysis initiation: One-year follow-up multicenter studyYoshihiro Takamura, Takehiro Matsumura, Kishiko Ohkoshi, et al.
Scientific Reports|October 21, 2025
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyesFumiko Murao, Ryoji Yanai, Sentaro Kusuhara, et al.
Current Eye Research|May 30, 2014
Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetesMasayuki Yasuda, Masahiko Shimura, Hiroshi Kunikata, et al.
Acta Ophthalmologica|February 12, 2019
Scleral buckling versus vitrectomy for young japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery: real-world evidence from a multicentre study in JapanIngen Shu, Hiroto Ishikawa, Hiroki Nishikawa, et al.
Ophthalmology. Retina|March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO TrialsCarl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Japanese Journal of Ophthalmology|December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trialKiyoshi Suzuma, Toshinori Murata, Masahiko Shimura, et al.
Journal of Diabetes Investigation|September 12, 2018
Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in JapanMasahiko Sugimoto, Hideyuki Tsukitome, Fumiki Okamoto, et al.
Journal of Clinical Medicine|April 12, 2025
Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in JapanMasakazu Morioka, Yoshihiro Takamura, Shigeo Yoshida, et al.
Plos One|June 11, 2025
Factors that contribute to loss to follow-up in the medium term after initiation of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in Japanese patientsTakaaki Sugisawa, Fumi Gomi, Yuri Harada, et al.
Journal of Diabetes Investigation|April 7, 2022
Treatment of diabetic macular edema in real-world clinical practice: The effect of agingSentaro Kusuhara, Masahiko Shimura, Shigehiko Kitano, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Scientific Reports|May 10, 2020
Functional and anatomical changes in diabetic macular edema after hemodialysis initiation: One-year follow-up multicenter studyYoshihiro Takamura, Takehiro Matsumura, Kishiko Ohkoshi, et al.
Scientific Reports|October 21, 2025
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyesFumiko Murao, Ryoji Yanai, Sentaro Kusuhara, et al.
Current Eye Research|May 30, 2014
Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetesMasayuki Yasuda, Masahiko Shimura, Hiroshi Kunikata, et al.
Acta Ophthalmologica|February 12, 2019
Scleral buckling versus vitrectomy for young japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery: real-world evidence from a multicentre study in JapanIngen Shu, Hiroto Ishikawa, Hiroki Nishikawa, et al.
Ophthalmology. Retina|March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO TrialsCarl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Japanese Journal of Ophthalmology|December 26, 2025
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trialKiyoshi Suzuma, Toshinori Murata, Masahiko Shimura, et al.
Journal of Diabetes Investigation|September 12, 2018
Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in JapanMasahiko Sugimoto, Hideyuki Tsukitome, Fumiki Okamoto, et al.
Journal of Clinical Medicine|April 12, 2025
Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in JapanMasakazu Morioka, Yoshihiro Takamura, Shigeo Yoshida, et al.
Plos One|June 11, 2025
Factors that contribute to loss to follow-up in the medium term after initiation of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in Japanese patientsTakaaki Sugisawa, Fumi Gomi, Yuri Harada, et al.
Journal of Diabetes Investigation|April 7, 2022
Treatment of diabetic macular edema in real-world clinical practice: The effect of agingSentaro Kusuhara, Masahiko Shimura, Shigehiko Kitano, et al.
Pageof 13